IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,952 | +110.3% | 506 | +90.2% | 0.00% | – |
| Q2 2023 | $10,914 | -5.8% | 266 | -17.9% | 0.00% | – |
| Q1 2023 | $11,580 | -2.0% | 324 | +3.5% | 0.00% | – |
| Q4 2022 | $11,822 | -21.2% | 313 | -6.8% | 0.00% | – |
| Q3 2022 | $15,000 | +15.4% | 336 | -7.2% | 0.00% | – |
| Q2 2022 | $13,000 | 0.0% | 362 | 0.0% | 0.00% | – |
| Q1 2022 | $13,000 | -38.1% | 362 | -48.7% | 0.00% | – |
| Q4 2021 | $21,000 | -81.4% | 705 | -79.0% | 0.00% | -100.0% |
| Q3 2021 | $113,000 | -8.9% | 3,356 | +7.8% | 0.00% | 0.0% |
| Q2 2021 | $124,000 | -100.0% | 3,112 | -78.8% | 0.00% | -66.7% |
| Q1 2021 | $660,192,000 | +216356.4% | 14,684 | +172.6% | 0.01% | -14.3% |
| Q4 2020 | $305,000 | +25.0% | 5,387 | +4.6% | 0.01% | +16.7% |
| Q3 2020 | $244,000 | -17.0% | 5,152 | +3.3% | 0.01% | -25.0% |
| Q2 2020 | $294,000 | +66.1% | 4,987 | +33.1% | 0.01% | +33.3% |
| Q1 2020 | $177,000 | -21.7% | 3,747 | 0.0% | 0.01% | -14.3% |
| Q4 2019 | $226,000 | +0.9% | 3,747 | 0.0% | 0.01% | -12.5% |
| Q3 2019 | $224,000 | +10.3% | 3,747 | +18.1% | 0.01% | +14.3% |
| Q2 2019 | $203,000 | -25.1% | 3,172 | -5.0% | 0.01% | -36.4% |
| Q1 2019 | $271,000 | +55.7% | 3,340 | -0.8% | 0.01% | +37.5% |
| Q3 2018 | $174,000 | +20.0% | 3,366 | -3.6% | 0.01% | -11.1% |
| Q2 2018 | $145,000 | -4.0% | 3,491 | +1.6% | 0.01% | -10.0% |
| Q1 2018 | $151,000 | -42.1% | 3,437 | -33.9% | 0.01% | -50.0% |
| Q4 2017 | $261,000 | +161.0% | 5,198 | +163.2% | 0.02% | +100.0% |
| Q3 2017 | $100,000 | 0.0% | 1,975 | 0.0% | 0.01% | -9.1% |
| Q2 2017 | $100,000 | +809.1% | 1,975 | +593.0% | 0.01% | +450.0% |
| Q1 2017 | $11,000 | – | 285 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |